HUTCHMED (China) Limited reported $205M of revenue over the trailing twelve months. 8 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $205M (to Q4 2019). Net income: −$106M, trailing twelve months to Q4 2019. Free cash flow: −$89M, trailing twelve months to Q4 2019. Operating margin: −71%, trailing twelve months to Q4 2019.

HCMHUTCHMED (China) Limited

Healthcare

$14.04-18% 1Y

$14.04

$9.9952 weeks$16.66

HCM as reported

HUTCHMED (China) Limited reported $205M of revenue over the trailing twelve months. 8 reported series are charted on this page, each one as filed.

$205M

Revenue, trailing twelve months · to Q4 2019 · every figure below is as filed, with no scoring applied

Net income: −$106M
Net income · trailing twelve months to Q4 2019
Free cash flow: −$89M
Free cash flow · trailing twelve months to Q4 2019
Operating margin: −71%
Operating margin · trailing twelve months to Q4 2019

Details›

Every series Ryufin has for HCM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$205M	n/a	Q4 2019
Net income	−$106M	n/a	Q4 2019
Operating margin	−71%	n/a	Q4 2019
Net margin	−52%	n/a	Q4 2019
ROE	−28%	n/a	Q4 2019
ROA	−19%	n/a	Q4 2019
ROIC	−88%	n/a	Q4 2019
Free cash flow	−$89M	n/a	Q4 2019

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.